HighTower Advisors
ACTU

HighTower Advisors’s Actuate Therapeutics ACTU Stock Holding History

HighTower Advisors’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8K Buy
+36,461
New +$84.5K ﹤0.01% 3719

Other funds holding ACTU

TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HighTower Advisors's ACTU Position: Q2 2026 in Review

HighTower Advisors opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 36,461 shares worth $55.8K. The stake represents ﹤0.01% of the portfolio and ranks #3719 among its holdings.

31 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • HighTower Advisors held 36,461 shares of Actuate Therapeutics worth $55.8K as of Q2 2026.
  • Actuate Therapeutics was a new HighTower Advisors position in Q2 2026.
  • Actuate Therapeutics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3719 holding.
  • 31 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.